PA
CBAY

Parallel Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Parallel Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-730
Closed -$17.2K – 3447
2023
Q4 		$17.2K Buy
730
+636
+677% +$11.3K ﹤0.01% 2028
2023
Q3 		$1.4K Buy
+94
New +$1.25K ﹤0.01% 2906
2023
Q2 		– Sell
-41
Closed -$358 – 3558
2023
Q1 		$358 Buy
+41
New +$328 ﹤0.01% 3206
2022
Q4 		– Sell
-1
Closed – – 3562
2022
Q3 		$0 Hold
1
– – ﹤0.01% 3590
2022
Q2 		$0 Hold
1
– – ﹤0.01% 3448
2022
Q1 		$0 Buy
+1
New +$3 ﹤0.01% 3359
2017
Q3 		– Sell
-400
Closed -$3K – 2249
2017
Q2 		$3K Buy
+400
New +$1.7K ﹤0.01% 1801

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Parallel Advisors's CBAY Position: Q1 2024 in Review

Parallel Advisors sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 730 shares — an estimated $17.2K sold.

Parallel Advisors first reported a position in CBAY in Q2 2017 and held it in 7 quarters. The position peaked at $17.2K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Parallel Advisors reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Parallel Advisors sold 730 Cymabay Therapeutics shares in Q1 2024, an estimated $17.2K.
  • Parallel Advisors first reported a position in Cymabay Therapeutics in Q2 2017 and held it in 7 quarters.
  • Parallel Advisors's Cymabay Therapeutics position peaked at $17.2K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Parallel Advisors's 13F filing for Q1 2024, filed 6 May 2024.